Chesley Taft & Associates LLC Astrazeneca PLC Transaction History
Chesley Taft & Associates LLC
- $2.47 Billion
- Q4 2025
A detailed history of Chesley Taft & Associates LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 152,750 shares of AZN stock, worth $13.7 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
152,750
Previous 126,765
20.5%
Holding current value
$13.7 Million
Previous $9.73 Million
40.41%
% of portfolio
0.55%
Previous 0.42%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,541Shares Held
503MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...